Literature DB >> 33198566

Synaptic Dysfunction in Huntington's Disease: Lessons from Genetic Animal Models.

Carlos Cepeda1, Michael S Levine1.   

Abstract

The understanding of the functional and structural changes occurring in the cerebral cortex and basal ganglia in Huntington's disease (HD) has benefited considerably from the generation of genetic animal models. Most studies of synaptic alterations in HD models have focused on the striatum, but a more complete picture of synaptic dysfunction in the cortico-basal ganglia-cortical loop is emerging. Here, we provide a review and analysis of current developments in the study of synaptic alterations in these areas using HD rodent models. Recent evidence indicates that cortical maldevelopment plays a role in synaptic dysfunction along the corticostriatal pathway that may have its roots in the way mutant huntingtin interacts with synaptic proteins. Furthermore, a progressive disconnection in the corticostriatal pathway leads to abnormal function engaging extrasynaptic N-methyl-D-aspartate glutamate receptors that contribute to eventual cell degeneration. In addition, biphasic increases followed by decreases in glutamate and dopamine release in the striatum could explain contrasting symptomatology in early and late stages of the disease. Changes in striatal output regions also are beginning to be examined. Finally, we highlight some therapeutic avenues aimed at rescuing synaptic dysfunction.

Entities:  

Keywords:  Huntington’s disease; basal ganglia; dopamine; genetic models; glutamate; striatum; synaptic activity

Mesh:

Substances:

Year:  2020        PMID: 33198566      PMCID: PMC9332072          DOI: 10.1177/1073858420972662

Source DB:  PubMed          Journal:  Neuroscientist        ISSN: 1073-8584            Impact factor:   7.235


  188 in total

1.  Synaptic scaling up in medium spiny neurons of aged BACHD mice: A slow-progression model of Huntington's disease.

Authors:  Anne B Rocher; Paolo Gubellini; Nicolas Merienne; Lydie Boussicault; Fanny Petit; Pauline Gipchtein; Caroline Jan; Philippe Hantraye; Emmanuel Brouillet; Gilles Bonvento
Journal:  Neurobiol Dis       Date:  2015-11-25       Impact factor: 5.996

2.  Excitatory GABAergic effects in striatal projection neurons.

Authors:  Enrico Bracci; Stefano Panzeri
Journal:  J Neurophysiol       Date:  2005-10-26       Impact factor: 2.714

Review 3.  Therapeutic effects of stem cells in rodent models of Huntington's disease: Review and electrophysiological findings.

Authors:  Sandra M Holley; Talia Kamdjou; Jack C Reidling; Brian Fury; Dane Coleal-Bergum; Gerhard Bauer; Leslie M Thompson; Michael S Levine; Carlos Cepeda
Journal:  CNS Neurosci Ther       Date:  2018-03-06       Impact factor: 5.243

4.  Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF.

Authors:  Carlos Cepeda; Amaal J Starling; Nanping Wu; Oanh K Nguyen; Besim Uzgil; Takahiro Soda; Veronique M André; Marjorie A Ariano; Michael S Levine
Journal:  J Neurosci Res       Date:  2004-12-15       Impact factor: 4.164

5.  Enhanced striatopallidal gamma-aminobutyric acid (GABA)A receptor transmission in mouse models of huntington's disease.

Authors:  Tamara Perez-Rosello; Simon Gelman; Geoffrey Tombaugh; Roger Cachope; Vahri Beaumont; D James Surmeier
Journal:  Mov Disord       Date:  2019-02-06       Impact factor: 10.338

6.  Cortical efferents lacking mutant huntingtin improve striatal neuronal activity and behavior in a conditional mouse model of Huntington's disease.

Authors:  Ana María Estrada-Sánchez; Courtney L Burroughs; Stephen Cavaliere; Scott J Barton; Shirley Chen; X William Yang; George V Rebec
Journal:  J Neurosci       Date:  2015-03-11       Impact factor: 6.167

7.  Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study.

Authors:  Kevin Duff; Jane S Paulsen; Leigh J Beglinger; Douglas R Langbehn; Julie C Stout
Journal:  Biol Psychiatry       Date:  2007-05-03       Impact factor: 13.382

8.  Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study.

Authors:  Y P Deng; R L Albin; J B Penney; A B Young; K D Anderson; A Reiner
Journal:  J Chem Neuroanat       Date:  2004-06       Impact factor: 3.052

Review 9.  Repurposing of the β-Lactam Antibiotic, Ceftriaxone for Neurological Disorders: A Review.

Authors:  Ebrahim M Yimer; Hailemichael Zeru Hishe; Kald Beshir Tuem
Journal:  Front Neurosci       Date:  2019-03-26       Impact factor: 4.677

Review 10.  Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders.

Authors:  Giles E Hardingham; Hilmar Bading
Journal:  Nat Rev Neurosci       Date:  2010-09-15       Impact factor: 34.870

View more
  8 in total

1.  Calcium dysregulation and compensation in cortical pyramidal neurons of the R6/2 mouse model of Huntington's disease.

Authors:  Katerina D Oikonomou; Elissa J Donzis; Minh T N Bui; Carlos Cepeda; Michael S Levine
Journal:  J Neurophysiol       Date:  2021-09-01       Impact factor: 2.974

2.  Thalamocortical Projections Are Significantly Impaired in the R6/2 Mouse Model of Huntington's Disease.

Authors:  S M Holley; K D Oikonomou; C M Swift; L Mohan; B Matthews; O Vega; G Mkrtchyan; C Cepeda; M S Levine
Journal:  eNeuro       Date:  2022-06-22

Review 3.  Recurrent Implication of Striatal Cholinergic Interneurons in a Range of Neurodevelopmental, Neurodegenerative, and Neuropsychiatric Disorders.

Authors:  Lauren A Poppi; Khue Tu Ho-Nguyen; Anna Shi; Cynthia T Daut; Max A Tischfield
Journal:  Cells       Date:  2021-04-15       Impact factor: 6.600

4.  BACHD Mice Recapitulate the Striatal Parvalbuminergic Interneuron Loss Found in Huntington's Disease.

Authors:  Vyshnavi Rallapalle; Annesha C King; Michelle Gray
Journal:  Front Neuroanat       Date:  2021-05-24       Impact factor: 3.856

Review 5.  Striatal Chloride Dysregulation and Impaired GABAergic Signaling Due to Cation-Chloride Cotransporter Dysfunction in Huntington's Disease.

Authors:  Melissa Serranilla; Melanie A Woodin
Journal:  Front Cell Neurosci       Date:  2022-01-14       Impact factor: 5.505

Review 6.  Non-Cell Autonomous and Epigenetic Mechanisms of Huntington's Disease.

Authors:  Chaebin Kim; Ali Yousefian-Jazi; Seung-Hye Choi; Inyoung Chang; Junghee Lee; Hoon Ryu
Journal:  Int J Mol Sci       Date:  2021-11-19       Impact factor: 5.923

Review 7.  Synaptic pathology in Huntington's disease: Beyond the corticostriatal pathway.

Authors:  Joshua Barry; Minh T N Bui; Michael S Levine; Carlos Cepeda
Journal:  Neurobiol Dis       Date:  2021-11-27       Impact factor: 7.046

8.  Early impairment of thalamocortical circuit activity and coherence in a mouse model of Huntington's disease.

Authors:  Justin L Shobe; Elissa J Donzis; Kwang Lee; Samiksha Chopra; Sotiris C Masmanidis; Carlos Cepeda; Michael S Levine
Journal:  Neurobiol Dis       Date:  2021-07-16       Impact factor: 5.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.